Table 4.
The DQ2- γ-II epitope in transcripts ofT.aestivum
| 1 2 3 4 5 6 7 8 9 | locus | group | % | ||
|---|---|---|---|---|---|
| LVQGQGI |
IQPQQPAQL |
EVIRSLVLGTLPTMCN |
Gli-A1 |
6 |
19 |
| LVQGQGI |
IQPQQPAQY |
EVIRSLVLRTLPNMCN |
Gli-A1 |
7 |
5 |
| LVQGQGI |
IQPQQPAQL |
EVIRSLVLRTLPTMCN |
Gli-B1 |
3 |
6 |
| LVQGQGI |
IQPQQLAQL |
EAIRSLVLQTLPTMCN |
Gli-B1 |
8 |
3 |
| LAQGLGI |
IQPQQPAQL |
EGIRSLVLKTLPTMCN |
Gli-B1 |
5 |
17 |
| LVQGQGI |
IQPQQPAQL |
EAIRSLVLQTLPSMCN |
Gli-D1 |
9 |
41 |
| LVQGQGI | IQPQQPAQL | EAIRSLVLQTLPTMCN | Gli-D1 | 10 | 9 |
Natural variants of γ-II (glia-γ30; IQPQQPAQ) epitope in expressed γ-gliadins of T.aestivum. This epitope is located in the C-terminal part of γ-gliadins (domain V). % = fraction of total number of γ-gliadins transcripts. Glutamine residues that are a primary targets for the enzyme tissue transglutaminase are to depicted in bold (Q) in QxP target sites whereas moderate target sites are depicted in italics, (Q) [13,14]. Cleavage sites: R, K in bold, trypsin; cleavage occurs at the right side (C-terminal direction) of the marked amino acid.